Gastric Degradation of Lipid-Based Supplements

The Science

Doing What Matters, Scientifically.

Gastric Degradation of Lipid-Based Supplements

The Gastric Phase of Lipid Digestion

Gastric Phase of Lipid Digestion

Lipid-based supplements, such as fish oil or plant-derived oils, deliver essential fatty acids and bioactive lipids. However, the journey through the digestive tract begins with a hostile environment. Within minutes of ingestion, the capsule is exposed to stomach acid (pH 1–3) and a mixture of enzymes. Gastric lipase—secreted by chief cells—initiates the hydrolysis of triglycerides into free fatty acids and diacylglycerols. Pepsin, primarily known for protein digestion, also disrupts lipid-protein complexes. As noted in a review of digestive enzymes, these enzymes break down proteins, carbohydrates and lipids, and supplementation can support digestive disorders. While the cited review focuses on enzyme supplementation, it underscores that lipid digestion begins in the stomach.
Microscopic view of lipids or cellular structures

Advanced Formulations Preserve Lipid Bioavailability

Gastric degradation poses challenges for uncoated lipid supplements. Free fatty acids released in the stomach are prone to oxidation, especially in the presence of oxygen and acidic conditions. Oxidized lipids not only lose efficacy but may produce reactive aldehydes that irritate the gastric mucosa. Moreover, lipids can aggregate in the aqueous gastric environment, reducing their dispersion and subsequent absorption. To protect sensitive lipids, enteric-coating technologies have been developed. These coatings resist low gastric pH but dissolve in the higher pH of the small intestine, ensuring that the lipids are delivered intact for absorption. Emulsion-based formulations, liposomes and self-microemulsifying drug delivery systems (SMEDDS) further stabilize lipids and improve bioavailability.

Celloré's enteric-coated softgels illustrate this principle. By incorporating a pH-sensitive polymer, the softgels remain intact in the stomach but release their contents in the duodenum. This design not only reduces fishy aftertaste but also minimises oxidative degradation. The inclusion of antioxidants (e.g., vitamin E) in the formulation further protects the lipids from peroxide formation. For consumers, this means that the fatty acids promised on the label are more likely to reach the bloodstream. However, even enteric coatings are not infallible; factors such as gastric emptying time, concurrent medications (e.g., proton pump inhibitors) and individual variations in pH can affect release profiles. Continued research on gastric degradation will inform better designs for lipid-based nutraceuticals, ensuring that consumers receive the health benefits associated with essential fatty acids.

back to the beginning